Zeltiq Unveils Estimated Terms for Smaller IPO
Published: Oct 07, 2011
Zeltiq Aesthetics Inc. unveiled estimated terms for a slightly smaller initial public offering as the company aims to raise funds to commercialize its fat-bulge reduction technology. The IPO of 7 million shares includes 6.7 million shares from the company and 307,000 shares from selling stockholders, according to its filing with the filing with the U.S. Securities and Exchange Commission. The estimated price range is $14 a share to $16 a share. The medical-technology company, which is focused on products that use its controlled-cooling technology platform, in July initially had filed for an IPO of up to $115 million.